Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Episode 17 January 12, 2022 00:39:58
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Jan 12 2022 | 00:39:58

/

Show Notes

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).

Other Episodes

Episode 16

December 15, 2021 00:58:27
Episode Cover

Episode 16: Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi

Welcome to a special epsiode of Few & Far Between. Our guest this week is oncologist Dr. Alex Adjei, Scientific Advisory Board Member at...

Listen

Episode 3

June 09, 2021 00:39:48
Episode Cover

Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be discussing insights into market research solutions for rare...

Listen

Episode 42

July 16, 2024 00:36:14
Episode Cover

Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...

Listen